Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14phosphorylation influenced TLR4 activation

International Immunopharmacology

Volumn 23, Issue 1, 2014, Pages 236-246

  Sun, Li Na ^a   Yang, Zhi Ying ^a   Lv, Sha Sha ^a   Liu, Xiang Chun ^a   Guan, Guang Ju ^a   Liu, Gang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Caveolin 1; Curcumin; Cytokines; Macrophage; TLR4

Indexed keywords

CAVEOLIN 1; CURCUMIN; GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; STREPTOZOCIN; TOLL LIKE RECEPTOR 4; TYROSINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DRUG EFFECT; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; GLOMERULUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY FIBROSIS; MACROPHAGE; MALE; NEPHRITIS; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECOMBINANT PLASMID; ADVERSE EFFECTS; ANIMAL; CELL CULTURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC DIET; DIABETIC NEPHROPATHIES; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY; METABOLISM; MUTATION; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN ENGINEERING; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAVEOLIN 1; CELLS, CULTURED; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC DIET; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY; MALE; MUTATION; PHOSPHORYLATION; PODOCYTES; PROTEIN ENGINEERING; RATS; RATS, WISTAR; TOLL-LIKE RECEPTOR 4; TYROSINE;

EID: 84907462671     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.08.023     Document Type: Article

References (46)

1. A.J. Collins, R.N. Foley, C. Herzog, B. Chavers, D. Gilbertson, and A. Ishani US Renal Data System 2012 annual data report Am J Kidney Dis 61 A7 2013 e1 e476
2. H. Zong, M. Ward, A. Madden, P.H. Yong, G.A. Limb, and T.M. Curtis Hyperglycaemia-induced pro-inflammatory responses by retinal Muller glia are regulated by the receptor for advanced glycation end-products (RAGE) Diabetologia 53 12 2010 2656 2666
3. T. Tang, J. Zhang, and J. Yin Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure J Biol Chem 285 7 2010 4637 4644
4. Y. Pan, Y. Wang, L. Cai, Y. Cai, J. Hu, and C. Yu Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats Br J Pharmacol 166 3 2012 1169 1182
5. S.K. Jain, J. Rains, J. Croad, B. Larson, and K. Jones Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats Antioxid Redox Signal 11 2 2009 241 249
6. Y. Gu, H.M. Lee, N. Napolitano, M. Clemens, Y. Zhang, and T. Sorsa 4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation Mediators Inflamm 2013 2013 329740
7. Y. Fu, R. Gao, Y. Cao, M. Guo, Z. Wei, and E. Zhou Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-kappaB signaling pathway in lipopolysaccharide-induced mastitis in mice Int Immunopharmacol 20 1 2014 54 58
8. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2 2001 675 680
9. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511
10. M.R. Dasu, S. Devaraj, L. Zhao, D.H. Hwang, and I. Jialal High glucose induces toll-like receptor expression in human monocytes: mechanism of activation Diabetes 57 2008 3090 3098
11. M.R. Dasu, and I. Jialal Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors Am J Physiol Endocrinol Metab 300 2011 E145 E154
12. M.K. Mirza, J. Yuan, X.P. Gao, S. Garrean, V. Brovkovych, and A.B. Malik Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation Am J Pathol 176 5 2010 2344 2351
13. T.H. Tsai, S.F. Chen, T.Y. Huang, C.F. Tzeng, A.S. Chiang, and Y.R. Kou Impaired Cd14 and Cd36 expression, bacterial clearance, and Toll-like receptor 4-Myd88 signaling in caveolin-1-deleted macrophages and mice Shock 35 1 2011 92 99
14. L. Cai, F. Yi, Z. Dai, X. Huang, Y.D. Zhao, and M.K. Mirza Loss of caveolin-1 and adiponectin induces severe inflammatory lung injury following LPS challenge through excessive oxidative/nitrative stress Am J Physiol Lung Cell Mol Physiol 306 6 2014 L566 L573
15. F.A. Medina, C.J. de Almeida, E. Dew, J. Li, G. Bonuccelli, and T.M. Williams Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar typhimurium infection Infect Immun 74 12 2006 6665 6674
16. H. Feng, L. Guo, Z. Song, H. Gao, D. Wang, and W. Fu Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis J Biol Chem 285 2010 25154 25160
17. V. Sathish, M.A. Thompson, S. Sinha, G.C. Sieck, Y.S. Prakash, and C.M. Pabelick Inflammation, caveolae and CD38-mediated calcium regulation in human airway smooth muscle Biochim Biophys Acta 1843 2 2014 346 351
18. X.M. Wang, H.P. Kim, K. Nakahira, S.W. Ryter, and A.M. Choi The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1 J Immunol 182 2009 3809 3818
19. H. Jiao, Y. Zhang, Z. Yan, Z.G. Wang, G. Liu, and R.D. Minshall Caveolin-1 Tyr14 phosphorylation induces interaction with TLR4 in endothelial cells and mediates MyD88-dependent signaling and sepsis-induced lung inflammation J Immunol 191 2013 6191 6199
20. G.H. Tesch Macrophages and diabetic nephropathy Semin Nephrol 30 2010 290 301
21. D. Min, J.G. Lyons, J. Bonner, S.M. Twiqq, D.K. Yue, and S.V. McLennan Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy Am J Physiol Renal Physiol 297 2009 1229 1237
22. P. Kumar, K. Natarajan, and N. Shanmugam High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression Cell Signal 26 3 2014 528 539
23. P. Vilekar, S. Awasthi, A. Natarajan, S. Anant, and V. Awasthi EF24 suppresses maturation and inflammatory response in dendritic cells Int Immunol 24 7 2012 455 464
24. J.S. Jurenka Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research Altern Med Rev 14 2009 141
25. F.Y. Chow, D.J. Nikolic-Paterson, E. Ozols, R.C. Atkins, B.J. Rollin, and G.H. Tesch Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice Kidney Int 69 2006 73 80
26. K. Moreth, H. Frey, M. Hubo, J. Zeng-Brouwers, M.V. Nastase, and L.T. Hsieh Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury Matrix Biol 35 2014 143 151
27. J. Reiser, G.G. von, M. Loos, J. Oh, K. Asanuma, L. Giardino, and M.P. Rastaldi Induction of B7-1 in podocytes is associated with nephrotic syndrome J Clin Invest 113 10 2004 1390 1397
28. H.J. Anders, B. Banas, and D. Schlondorff Signaling danger: Toll-like receptors and their potential roles in kidney disease J Am Soc Nephrol 15 4 2004 854 867
29. W.P. Pulskens, G.J. Teske, L.M. Butter, J.J. Roelofs, T. van der Poll, and S. Florquin Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury PLoS One 3 10 2008 e3596
30. T. Eleftheriadis, and B.R. Lawson Toll-like receptors and kidney diseases Inflamm Allergy Drug Targets 8 3 2009 191 201
31. H.J. Anders Toll-like receptors and danger signaling in kidney injury J Am Soc Nephrol 21 8 2010 1270 1274
32. T. Bergler, U. Hoffmann, E. Bergler, B. Jung, M.C. Banas, and S.W. Reinhold Toll-like receptor 4 in experimental kidney transplantation: early mediator of endogenous danger signals Nephron Exp Nephrol 121 3-4 2012 e59 e70
33. T. Eleftheriadis, G. Pissas, V. Liakopoulos, I. Stefanidis, and B.R. Lawson Toll-like receptors and their role in renal pathologies Inflamm Allergy Drug Targets 11 6 2012 464 477
34. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 116 2006 3015 3025
35. M. Lin, and S.C. Tang Toll-like receptors: sensing and reacting to diabetic injury in the kidney Nephrol Dial Transplant 29 4 2014 746 754
36. M.C. Banas, B. Banas, K.L. Hudkins, T.A. Wietecha, M. Iyoda, and E. Bock TLR4 links podocytes with the innate immune system to mediate glomerular injury J Am Soc Nephrol 19 4 2008 704 713
37. H. Gradisar, M.M. Keber, P. Pristovsek, and R. Jerala MD-2 as the target of curcumin in the inhibition of response to LPS J Leukoc Biol 82 2007 968
38. H.S. Youn, S.I. Saitoh, K. Miyake, and D.H. Hwang Inhibition of homodimerization of Toll-like receptor 4 by curcumin Biochem Pharmacol 72 1 2006 62 69
39. T. Matsui, Y. Higashimoto, J. Taira, and S. Yamagishi Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells Biochem Biophys Res Commun 441 2 2013 405 410
40. X.X. Wang, Z. Wu, H.F. Huang, C. Han, W. Zou, and J. Liu Caveolin-1, through its ability to negatively regulate TLR4, is a crucial determinant of MAPK activation in LPS-challenged mammary epithelial cells Asian Pac J Cancer Prev 14 4 2013 2295 2299
41. P.X. Zhang, T.S. Murray, V.R. Villella, E. Ferrari, S. Esposito, and A. D'Souza Reduced caveolin-1 promotes hyperinflammation due to abnormal heme oxygenase-1 localization in lipopolysaccharide-challenged macrophages with dysfunctional cystic fibrosis transmembrane conductance regulator J Immunol 190 10 2013 5196 5206
42. X.M. Wang, H.P. Kim, R. Song, and A.M. Choi Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway Am J Respir Cell Mol Biol 34 4 2006 434 442
43. K.A. Walton, B.G. Gugiu, M. Thomas, R.J. Basseri, D.R. Eliav, and R.G. Salomon A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products J Lipid Res 47 9 2006 1967 1974
44. G.H. Tesch, and T.J. Allen Rodent models of streptozotocin-induced diabetic nephropathy Nephrology (Carlton) 12 3 2007 261 266
45. J. Huang, K. Huang, T. Lan, X. Xie, X. Shen, and P. Liu Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway Mol Cell Endocrinol 365 2 2013 231 240
46. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol Pharm 4 6 2007 807 818